scholarly article | Q13442814 |
P356 | DOI | 10.1097/01.RHU.0000221794.24431.36 |
P698 | PubMed publication ID | 16755237 |
P2093 | author name string | Jian Li | |
Wei-Gang Fang | |||
Xiao-Ming Huang | |||
Xue-Jun Zeng | |||
P433 | issue | 3 | |
P921 | main subject | Pneumocystis carinii | Q2099992 |
pneumonia | Q12192 | ||
P304 | page(s) | 114-117 | |
P577 | publication date | 2006-06-01 | |
P1433 | published in | Journal of Clinical Rheumatology | Q15766312 |
P1476 | title | Pneumocystis carinii pneumonia in patients with connective tissue disease. | |
P478 | volume | 12 |
Q45763211 | A dose-escalation regimen of trimethoprim-sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases |
Q37947196 | Clinical conditions associated with PCP in children. |
Q80199686 | Comparison of trimethoprim-sulfamethoxazole and aerosolized pentamidine for primary prophylaxis of Pneumocystis jiroveci pneumonia in immunocompromised patients with connective tissue disease |
Q38692232 | Current and emerging treatment options for interstitial lung disease in patients with rheumatic disease |
Q38084889 | Diagnosis and management of infectious complications of childhood rheumatic diseases |
Q38149856 | Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies |
Q38794907 | Pneumocystis Pneumonia and the Rheumatologist: Which Patients Are At Risk and How Can PCP Be Prevented? |
Q35793693 | Pneumocystis Pneumonia in Patients with Autoimmune Diseases: A Retrospective Study Focused on Clinical Characteristics and Prognostic Factors Related to Death |
Q38786977 | Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions: a systematic review with recommendations for prophylaxis |
Q38221817 | Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases |
Q36948496 | Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care |
Q54052789 | Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies. |
Q37597971 | Red fist and muscle weakness with a rare complication |
Q46337694 | Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus |
Q39062899 | The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review |
Search more.